Improving the safety of immunotherapy

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 2, 2014, Pages 131-135

  Rank, Matthew A ^a   Bernstein, David I ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Desensitization; Hypersensitivity; Immunologic; Immunotherapy

Indexed keywords

ADRENALIN; CORTICOSTEROID; DIPHENHYDRAMINE; POLLEN EXTRACT; PREDNISONE; SALBUTAMOL;

ADULT; ALLERGIC RHINITIS; ASTHMA; CASE REPORT; CHEST TIGHTNESS; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DISEASE CONTROL; DISEASE EXACERBATION; EVIDENCE BASED MEDICINE; FEMALE; FLUSHING; HUMAN; IATROGENIC DISEASE; MEDICATION ERROR; NASAL PRURITUS; NOSE OBSTRUCTION; PATIENT SAFETY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN TEST; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; WHEEZING;

DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGIC; IMMUNOTHERAPY;

ADULT; DESENSITIZATION, IMMUNOLOGIC; EPINEPHRINE; FEMALE; HUMANS; RISK ASSESSMENT; RISK MANAGEMENT; SKIN TESTS;

EID: 84895451753     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.09.017     Document Type: Review

References (35)

1. Cox L., Nelson H., Lockey R., Calabria C., Chacko T., Finegold I., et al. Allergen immunotherapy: a practice parameter third update. JAllergy Clin Immunol 2011, 127(Suppl 1):S1-S55.
2. Bernstein D.I., Wanner M., Borish L., Liss G.M. Twelve-year survey of fatal reactions to allergen injections and skin testing:1990-2001. JAllergy Clin Immunol 2004, 113:1129-1136.
3. Amin H.S., Liss G.M., Bernstein D.I. Evaluation of near-fatal reactions to allergen immunotherapy injections. JAllergy Clin Immunol 2006, 117:169-175.
4. Lockey R.F., Benedict L.M., Turkeltaub P.C., Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST). JAllergy Clin Immunol 1987, 79:660-677.
5. Reid M.J., Lockey R.F., Turkeltaub P.C., Platts-Mills T.A. Survey of fatalities from skin testing and immunotherapy 1985-1989. JAllergy Clin Immunol 1993, 92:6-15.
6. Epstein T.G., Liss G.M., Murphy-Berendts K., Bernstein D.I. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?. Ann Allergy Asthma Immunol 2013, 110:274-278. 278.e1.
7. Bousquet J., Hejjaoui A., Dhivert H., Clauzel A.M., Michel F.B. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract: systemic reactions during the rush protocol in patients suffering from asthma. JAlllergy Clin Immunol 1989, 83:797-802.
8. Lang D.M., Alpern M.B., Visintainer P.F., Smit S.T. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 1993, 153:2033-2040.
9. Toogood J.H. Beta-blocker therapy and the risk of anaphylaxis. CMAJ 1987, 136:929-933.
10. Hepner M.J., Ownby D.R., Anderson J.A., Rowe M.S., Sears-Ewald D., Brown E.B. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. JAllergy Clin Immunol 1990, 86:407-411.
11. Rueff F., Pryzbilla B., Bilo M.B., Muller U., Scheipl F., Aberer W., et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Inset Venom Hypersensitivity. JAllergy Clin Immunol 2009, 124:1047-1054.
12. White K.M., England R.W. Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy. Ann Allergy Asthma Immunol 2008, 101:426-430.
13. Larenas Linnemann D.E.S., Hauswirth D.W., Calabria C.W., Sher L.D., Rank M.A. AAAAI survey on allergen immunotherapy (AIT) in patients with specific medical conditions. JAllergy Clin Immunol 2013, 131. A812. p. AB229.
14. Tinkelman D.G., Cole W.Q., Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. JAllergy Clin Immunol 1995, 95:8-14.
15. Lin M.S., Tanner E., Lynn J., Friday G.A. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993, 71:557-562.
16. Tankersley M.S., Butler K.K., Butler W.K., Goetz D.W. Local reactions during allergen immunotherapy do not require dose adjustment. JAllergy Clin Immunol 2000, 106:840-843.
17. Kelso J.M. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol 2004, 92:225-227.
18. Roy S.R., Sigmon J.R., Olivier J., Moffitt J.E., Brown D.A., Marshall G.D. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2007, 99:82-86.
19. Calabria C.W., Stolfi A., Tankersley The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions. Ann Allergy Asthma Immunol 2011, 106:49-53.
20. DaVeiga S.P., Liu X., Caruso K., Golubski S., Xu M., Lang D.M. Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment. Ann Allergy Asthma Immunol 2011, 106:533-537.
21. Cox L. Advantages and disadvantages of accelerated immunotherapy schedules. JAllergy Clin Immunol 2008, 122:432-434.
22. Copenhaver C.C., Parker A., Patch S. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Ann Allergy Asthma Immunol 2011, 107:441-447.
23. Aronson D.W., Gandhi T.K. Incorrect allergy injections: allergists' experiences and recommendations for prevention. JAllergy Clin Immunol 2004, 113:1117-1121.
24. Patel S., Rossow K.L., Williams B.J., Li J.T., Rank M.A. Errors in allergen immunotherapy: a systems assessment. Ann Allergy Asthma Immunol 2013, 110:205-206.
25. Brockow K., Keihn M., Riethmuller C., Vieluf D., Berger J., Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. JAllergy Clin Immunol 1997, 100:458-463.
26. Ohashi Y., Nakai Y., Murata K. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006, 96:600-605.
27. Casale T.B., Busse W.W., Kline J.N., Ballas Z.K., Moss M.H., Townley R.G., et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. JAllergy Clin Immunol 2006, 117:134-140.
28. Kamin W., Kopp M.V., Erdnuess F., Schauer U., Zielen S., Wahn U. Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allerg Immunol 2010, 21:e160-e165.
29. Lin S.Y., Erekosima N., Kim J.M., Ramanathan M., Suarez-Cuervo C., Chelladurai Y., et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013, 309:1278-1288.
30. Creticos P.S., Maloney J., Bernstein D.I., Casale T., Kaur A., Fisher R., et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. JAllergy Clin Immunol 2013, 131:1342-1349.
31. Nayak A.S., Atiee G.J., Dige E., Maloney J., Notle H. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis. Allergy Asthma Proc 2012, 33:404-410.
32. Roger A., Justicia J.L., Navarro LÁ, Eseverri J.L., Ferres J., Malet A., Alva V. Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites. Int Arch Allergy Immunol 2011, 154:69-75.
33. de Groot H., Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009, 64:963-964.
34. Phillips J.F., Lockey R.F., Fox R.W., Ledford D.K., Glaum M.C. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy Asthma Proc 2011, 32:288-294.
35. Epstein T.G., Liss G.M., Murphy-Berendts K., Berstein D.I. Immediate and delayed-onset reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy year 2. Ann Allergy Asthma Immunol 2011, 107:426-431.